Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, Utah; and
Department of Pathology, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Am J Physiol Lung Cell Mol Physiol. 2014 Dec 15;307(12):L970-7. doi: 10.1152/ajplung.00171.2014. Epub 2014 Oct 3.
Much of the progress in improved neonatal care, particularly management of underdeveloped preterm lungs, has been aided by investigations of multiple animal models, including the neonatal baboon (Papio species). In this article we highlight how the preterm baboon model at both 140 and 125 days gestation (term equivalent 185 days) has advanced our understanding and management of the immature human infant with neonatal lung disease. Not only is the 125-day baboon model extremely relevant to the condition of bronchopulmonary dysplasia but there are also critical neurodevelopmental and other end-organ pathological features associated with this model not fully discussed in this limited forum. We also describe efforts to incorporate perinatal infection into these preterm models, both fetal and neonatal, and particularly associated with Ureaplasma/Mycoplasma organisms. Efforts to rekindle the preterm primate model for future evaluations of therapies such as stem cell replacement, early lung recruitment interventions coupled with noninvasive surfactant and high-frequency nasal ventilation, and surfactant therapy coupled with antioxidant or anti-inflammatory medications, to name a few, should be undertaken.
在改进新生儿护理方面取得的许多进展,特别是对未成熟早产儿肺部的管理,都得益于对多种动物模型的研究,包括新生儿狒狒(Papio 种)。在本文中,我们强调了 140 天和 125 天胎龄(相当于 185 天)的早产狒狒模型如何促进了我们对患有新生儿肺部疾病的未成熟人类婴儿的理解和管理。125 天的狒狒模型不仅与支气管肺发育不良的情况极为相关,而且还存在与该模型相关的关键神经发育和其他终末器官病理特征,在这个有限的论坛中并未充分讨论。我们还描述了将围产期感染纳入这些早产模型中的努力,包括胎儿和新生儿感染,特别是与脲原体/支原体有关的感染。应该重新开展早产灵长类动物模型的研究,以评估未来的治疗方法,如干细胞替代、早期肺复张干预联合非侵入性表面活性剂和高频鼻通气,以及表面活性剂治疗联合抗氧化剂或抗炎药物等,不胜枚举。